Total submissions: 6
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV000466058 | SCV000556503 | benign | Tuberous sclerosis 2 | 2024-02-01 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV000572887 | SCV000675515 | likely benign | Hereditary cancer-predisposing syndrome | 2015-06-05 | criteria provided, single submitter | clinical testing | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
Gene |
RCV001704567 | SCV000730314 | benign | not provided | 2020-01-16 | criteria provided, single submitter | clinical testing | |
Genome- |
RCV000466058 | SCV002039886 | benign | Tuberous sclerosis 2 | 2021-11-07 | criteria provided, single submitter | clinical testing | |
Ce |
RCV001704567 | SCV002497864 | likely benign | not provided | 2022-12-01 | criteria provided, single submitter | clinical testing | TSC2: BP4, BP7 |
Sema4, |
RCV000572887 | SCV002534002 | likely benign | Hereditary cancer-predisposing syndrome | 2021-05-13 | criteria provided, single submitter | curation |